Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$738.8K
2 trades · 1 insiders
Net · 90d
$-738.8K
Insiders on file
26
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Megna Michael R | Chief Accounting Officer | 201 | $0 | $6.07M | 2026-09-03 |
| Moat Ross | Chief Commercial Officer | 163 | $0 | $5.83M | 2026-09-01 |
| Ragosa Mark | Interim CFO | 219 | $0 | $12.46M | 2026-09-01 |
| Paolini John F. | SVP & Chief Medical Officer | 199 | $0 | $14.04M | 2026-09-01 |
| Patel Sanj K | Chairman & CEO | 246 | $999.7K | $56.69M | 2026-09-01 |
| Quart Barry D | Director | 59 | $0 | $3.87M | 2026-08-19 |
| Levy Richard S | Director | 42 | $0 | $0 | 2026-08-01 |
| Cole G Bradley | Director | 24 | $0 | $598.2K | 2026-07-29 |
| Malkani Dhiraj H | CHIEF STRATEGY OFFICER | 6 | $0 | $0 | 2026-07-01 |
| McCain Tracey L | Director | 21 | $0 | $0 | 2026-05-29 |
| Malley Thomas | Director | 40 | $0 | $5.86M | 2026-05-29 |
| Popovits Kimberly J | Director | 26 | $0 | $0 | 2026-05-29 |
| BAKER JULIAN | Director, 10% Owner | 13 | $0 | $0 | 2026-05-29 |
| Tessari Eben | Chief Operating Officer | 199 | $0 | $19.65M | 2026-04-07 |
| Baker Brothers Life Sciences LP | Director, 10% Owner | 28 | $54.00M | $0 | 2024-10-04 |
| 667, L.P. | Director, 10% Owner | 6 | $0 | $0 | 2023-06-06 |
| Baker Bros. Advisors (GP) LLC | Director | 3 | $0 | $0 | 2022-06-29 |
| Pano Arian | Chief Clinical Dev. Officer | 2 | $0 | $0 | 2021-09-02 |
| Beetham Thomas W. | EVP & Chief Legal Officer | 26 | $100.0K | $2.11M | 2021-03-20 |
| Rizvi Qasim | Chief Commercial Officer | 7 | $0 | $0 | 2020-12-31 |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | 2 | $0 | $0 | 2020-05-18 |
| Mahoney Stephen F. | President & COO | 8 | $100.0K | $0 | 2019-09-17 |
| Heberlig Chris | Exec VP & CFO | 8 | $100.0K | $0 | 2019-09-17 |
| Cormorant Asset Management, LP | 10% Owner | 3 | $1.25M | $0 | 2018-05-29 |
| BOESS CARSTEN | 10% Owner | 5 | $100.0K | $0 | 2018-05-29 |
| Deerfield Mgmt L.P. | 10% Owner | 6 | $16.00M | $0 | 2018-05-29 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Megna Michael R | CHIEF ACCOUNTING OFFICER | S Sale | 2026-09-03 | 2026-09-03 | 4,600 | $80.30 | $369.4K | 29,062 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | S Sale | 2026-09-03 | 2026-09-03 | 4,600 | $80.30 | $369.4K | 29,062 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,362 | — | $0 | 4,725 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | A Award deriv | 2026-09-01 | 2026-09-03 | 3,650 | — | $0 | 3,650 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 3,932 | — | $0 | 0 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,558 | — | $0 | 2,557 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,644 | — | $0 | 7,931 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | A Award deriv | 2026-09-01 | 2026-09-03 | 14,600 | — | $0 | 14,600 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 1,740 | — | $0 | 3,481 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,457 | — | $0 | 7,371 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,477 | — | $0 | 0 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | A Award deriv | 2026-09-01 | 2026-09-03 | 9,250 | — | $0 | 9,250 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 1,611 | — | $0 | 1,611 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | A Award deriv | 2026-09-01 | 2026-09-03 | 36,950 | — | $0 | 36,950 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,497 | — | $0 | 0 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 1,624 | — | $0 | 1,624 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 1,750 | — | $0 | 3,500 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,457 | — | $0 | 7,371 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | A Award deriv | 2026-09-01 | 2026-09-03 | 26,750 | — | $0 | 26,750 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | A Award deriv | 2026-09-01 | 2026-09-03 | 6,700 | — | $0 | 6,700 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | A Award deriv | 2026-09-01 | 2026-09-03 | 30,050 | — | $0 | 30,050 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | A Award deriv | 2026-09-01 | 2026-09-03 | 120,150 | — | $0 | 120,150 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise deriv | 2026-09-01 | 2026-09-03 | 8,609 | — | $0 | 25,826 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise deriv | 2026-09-01 | 2026-09-03 | 6,237 | — | $0 | 12,475 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise deriv | 2026-09-01 | 2026-09-03 | 9,991 | — | $0 | 0 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise deriv | 2026-09-01 | 2026-09-03 | 6,481 | — | $0 | 6,481 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise deriv | 2026-09-01 | 2026-09-03 | 6,481 | — | $0 | 6,481 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise deriv | 2026-09-01 | 2026-09-03 | 9,991 | — | $0 | 0 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise deriv | 2026-09-01 | 2026-09-03 | 6,237 | — | $0 | 12,475 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise deriv | 2026-09-01 | 2026-09-03 | 8,609 | — | $0 | 25,826 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | A Award deriv | 2026-09-01 | 2026-09-03 | 120,150 | — | $0 | 120,150 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | A Award deriv | 2026-09-01 | 2026-09-03 | 30,050 | — | $0 | 30,050 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 1,750 | — | $0 | 1,750 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 1,591 | — | $0 | 3,182 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | A Award deriv | 2026-09-01 | 2026-09-03 | 7,800 | — | $0 | 7,800 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | A Award deriv | 2026-09-01 | 2026-09-03 | 31,150 | — | $0 | 31,150 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,694 | — | $0 | 0 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 3,069 | — | $0 | 9,206 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 2,644 | — | $0 | 39,193 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 3,932 | — | $0 | 31,629 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 2,558 | — | $0 | 34,187 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 2,362 | — | $0 | 36,549 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | F Tax w/h | 2026-09-01 | 2026-09-03 | 5,531 | $79.28 | $438.5K | 33,662 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 2,477 | — | $0 | 14,506 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 1,740 | — | $0 | 17,857 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 2,457 | — | $0 | 20,314 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | F Tax w/h | 2026-09-01 | 2026-09-03 | 4,007 | $79.28 | $317.7K | 16,307 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 1,611 | — | $0 | 16,117 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 2,497 | — | $0 | 68,120 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | F Tax w/h | 2026-09-01 | 2026-09-03 | 4,029 | $79.28 | $319.4K | 69,922 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 1,750 | — | $0 | 71,494 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 2,457 | — | $0 | 73,951 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 1,624 | — | $0 | 69,744 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise | 2026-09-01 | 2026-09-03 | 9,991 | — | $0 | 86,165 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise | 2026-09-01 | 2026-09-03 | 6,481 | — | $0 | 92,646 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | F Tax w/h | 2026-09-01 | 2026-09-03 | 15,144 | $79.28 | $1.20M | 92,348 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise | 2026-09-01 | 2026-09-03 | 8,609 | — | $0 | 107,492 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise | 2026-09-01 | 2026-09-03 | 6,237 | — | $0 | 98,883 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise | 2026-09-01 | 2026-09-03 | 8,609 | — | $0 | 107,492 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise | 2026-09-01 | 2026-09-03 | 9,991 | — | $0 | 86,165 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise | 2026-09-01 | 2026-09-03 | 6,481 | — | $0 | 92,646 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | F Tax w/h | 2026-09-01 | 2026-09-03 | 15,144 | $79.28 | $1.20M | 92,348 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise | 2026-09-01 | 2026-09-03 | 6,237 | — | $0 | 98,883 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 1,591 | — | $0 | 22,189 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 3,069 | — | $0 | 25,258 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | F Tax w/h | 2026-09-01 | 2026-09-03 | 4,404 | $79.28 | $349.1K | 20,854 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 1,750 | — | $0 | 20,598 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 2,694 | — | $0 | 18,848 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,477 | — | $0 | 0 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 1,611 | — | $0 | 1,611 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 1,740 | — | $0 | 3,481 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,457 | — | $0 | 7,371 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | A Award deriv | 2026-09-01 | 2026-09-03 | 36,950 | — | $0 | 36,950 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | A Award deriv | 2026-09-01 | 2026-09-03 | 9,250 | — | $0 | 9,250 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | F Tax w/h | 2026-09-01 | 2026-09-03 | 4,007 | $79.28 | $317.7K | 16,307 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 2,457 | — | — | 20,314 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 1,740 | — | — | 17,857 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 1,611 | — | — | 16,117 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 2,477 | — | — | 14,506 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,694 | — | $0 | 0 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 1,750 | — | $0 | 1,750 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 1,591 | — | $0 | 3,182 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 3,069 | — | $0 | 9,206 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | A Award deriv | 2026-09-01 | 2026-09-03 | 31,150 | — | $0 | 31,150 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | A Award deriv | 2026-09-01 | 2026-09-03 | 7,800 | — | $0 | 7,800 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | F Tax w/h | 2026-09-01 | 2026-09-03 | 4,404 | $79.28 | $349.1K | 20,854 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 3,069 | — | — | 25,258 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 1,591 | — | — | 22,189 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 1,750 | — | — | 20,598 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 2,694 | — | — | 18,848 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,497 | — | $0 | 0 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 1,624 | — | $0 | 1,624 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 1,750 | — | $0 | 3,500 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,457 | — | $0 | 7,371 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | A Award deriv | 2026-09-01 | 2026-09-03 | 26,750 | — | $0 | 26,750 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | A Award deriv | 2026-09-01 | 2026-09-03 | 6,700 | — | $0 | 6,700 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | F Tax w/h | 2026-09-01 | 2026-09-03 | 4,029 | $79.28 | $319.4K | 69,922 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 2,457 | — | — | 73,951 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 1,750 | — | — | 71,494 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 1,624 | — | — | 69,744 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 2,497 | — | — | 68,120 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO, Director | M Exercise deriv | 2026-09-01 | 2026-09-03 | 9,991 | — | $0 | 0 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO, Director | M Exercise deriv | 2026-09-01 | 2026-09-03 | 6,481 | — | $0 | 6,481 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO, Director | M Exercise deriv | 2026-09-01 | 2026-09-03 | 6,237 | — | $0 | 12,475 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO, Director | M Exercise deriv | 2026-09-01 | 2026-09-03 | 8,609 | — | $0 | 25,826 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO, Director | A Award deriv | 2026-09-01 | 2026-09-03 | 120,150 | — | $0 | 120,150 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO, Director | A Award deriv | 2026-09-01 | 2026-09-03 | 30,050 | — | $0 | 30,050 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO, Director | F Tax w/h | 2026-09-01 | 2026-09-03 | 15,144 | $79.28 | $1.20M | 92,348 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO, Director | M Exercise | 2026-09-01 | 2026-09-03 | 8,609 | — | — | 107,492 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO, Director | M Exercise | 2026-09-01 | 2026-09-03 | 6,237 | — | — | 98,883 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO, Director | M Exercise | 2026-09-01 | 2026-09-03 | 6,481 | — | — | 92,646 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO, Director | M Exercise | 2026-09-01 | 2026-09-03 | 9,991 | — | — | 86,165 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO, Director | M Exercise deriv | 2026-09-01 | 2026-09-03 | 9,991 | — | $0 | 0 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO, Director | M Exercise deriv | 2026-09-01 | 2026-09-03 | 6,481 | — | $0 | 6,481 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO, Director | M Exercise deriv | 2026-09-01 | 2026-09-03 | 6,237 | — | $0 | 12,475 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO, Director | M Exercise deriv | 2026-09-01 | 2026-09-03 | 8,609 | — | $0 | 25,826 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO, Director | A Award deriv | 2026-09-01 | 2026-09-03 | 120,150 | — | $0 | 120,150 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO, Director | A Award deriv | 2026-09-01 | 2026-09-03 | 30,050 | — | $0 | 30,050 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO, Director | F Tax w/h | 2026-09-01 | 2026-09-03 | 15,144 | $79.28 | $1.20M | 92,348 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO, Director | M Exercise | 2026-09-01 | 2026-09-03 | 8,609 | — | — | 107,492 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO, Director | M Exercise | 2026-09-01 | 2026-09-03 | 6,237 | — | — | 98,883 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO, Director | M Exercise | 2026-09-01 | 2026-09-03 | 6,481 | — | — | 92,646 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO, Director | M Exercise | 2026-09-01 | 2026-09-03 | 9,991 | — | — | 86,165 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 3,932 | — | $0 | 0 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,558 | — | $0 | 2,557 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,362 | — | $0 | 4,725 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,644 | — | $0 | 7,931 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | A Award deriv | 2026-09-01 | 2026-09-03 | 14,600 | — | $0 | 14,600 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | A Award deriv | 2026-09-01 | 2026-09-03 | 3,650 | — | $0 | 3,650 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | F Tax w/h | 2026-09-01 | 2026-09-03 | 5,531 | $79.28 | $438.5K | 33,662 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 2,644 | — | — | 39,193 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 2,362 | — | — | 36,549 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 2,558 | — | — | 34,187 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | M Exercise | 2026-09-01 | 2026-09-03 | 3,932 | — | — | 31,629 | SEC↗ |
| Quart Barry D | Director | G Gift | 2026-08-19 | 2026-08-21 | 2,600 | — | $0 | 12,745 | SEC↗ |
| Quart Barry D | Director | G Gift | 2026-08-19 | 2026-08-21 | 2,600 | — | $0 | 12,745 | SEC↗ |
| Levy Richard S | Director | A Award deriv | 2026-08-01 | 2026-08-04 | 403 | — | $0 | 403 | SEC↗ |
| Levy Richard S | Director | M Exercise deriv | 2026-08-01 | 2026-08-04 | 403 | — | $0 | 0 | SEC↗ |
| Levy Richard S | Director | M Exercise | 2026-08-01 | 2026-08-04 | 403 | — | $0 | 22,359 | SEC↗ |
| Levy Richard S | Director | M Exercise deriv | 2026-08-01 | 2026-08-04 | 403 | — | $0 | 0 | SEC↗ |
| Levy Richard S | Director | A Award deriv | 2026-08-01 | 2026-08-04 | 403 | — | $0 | 403 | SEC↗ |
| Levy Richard S | Director | M Exercise | 2026-08-01 | 2026-08-04 | 403 | — | — | 22,359 | SEC↗ |
| Cole G Bradley | Director | S Sale | 2026-07-29 | 2026-07-31 | 3,673 | $81.43 | $299.1K | 11,672 | SEC↗ |
| Cole G Bradley | Director | G Gift | 2026-07-29 | 2026-07-31 | 4,500 | — | $0 | 7,172 | SEC↗ |
| Cole G Bradley | Director | G Gift | 2026-07-29 | 2026-07-31 | 4,500 | — | $0 | 7,172 | SEC↗ |
| Cole G Bradley | Director | S Sale | 2026-07-29 | 2026-07-31 | 3,673 | $81.43 | $299.1K | 11,672 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | A Award | 2026-07-15 | 2026-09-03 | 279 | $33.50 | $9.3K | 27,697 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | A Award | 2026-07-15 | 2026-09-03 | 279 | $33.50 | $9.3K | 27,697 | SEC↗ |
| Malkani Dhiraj H | CHIEF STRATEGY OFFICER | A Award deriv | 2026-07-01 | 2026-07-06 | 82,600 | — | $0 | 0 | SEC↗ |
| Malkani Dhiraj H | CHIEF STRATEGY OFFICER | A Award deriv | 2026-07-01 | 2026-07-06 | 1,307 | — | $0 | 0 | SEC↗ |
| Malkani Dhiraj H | CHIEF STRATEGY OFFICER | A Award deriv | 2026-07-01 | 2026-07-06 | 1,245 | — | $0 | 0 | SEC↗ |
| Malkani Dhiraj H | CHIEF STRATEGY OFFICER | A Award deriv | 2026-07-01 | 2026-07-06 | 2,188 | — | $0 | 0 | SEC↗ |
| Malkani Dhiraj H | CHIEF STRATEGY OFFICER | A Award deriv | 2026-07-01 | 2026-07-06 | 14,000 | — | $0 | 0 | SEC↗ |
| Malkani Dhiraj H | CHIEF STRATEGY OFFICER | A Award deriv | 2026-07-01 | 2026-07-06 | 2,119 | — | $0 | 0 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | C Conversion deriv | 2026-06-01 | 2026-06-02 | 900,000 | — | $0 | 626,160 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | C Conversion | 2026-06-01 | 2026-06-02 | 900,000 | — | $0 | 951,794 | SEC↗ |
| BAKER JULIAN | Director | A Award deriv | 2026-05-29 | 2026-06-02 | 36,474 | — | $0 | 36,474 | SEC↗ |
| BAKER JULIAN | Director | A Award deriv | 2026-05-29 | 2026-06-02 | 36,474 | — | $0 | 36,474 | SEC↗ |
| Cole G Bradley | Director | A Award deriv | 2026-05-29 | 2026-06-02 | 12,158 | — | $0 | 12,158 | SEC↗ |
| Cole G Bradley | Director | A Award deriv | 2026-05-29 | 2026-06-02 | 2,026 | — | $0 | 2,026 | SEC↗ |
| Cole G Bradley | Director | M Exercise deriv | 2026-05-29 | 2026-06-02 | 2,799 | — | $0 | 0 | SEC↗ |
| Levy Richard S | Director | M Exercise deriv | 2026-05-29 | 2026-06-02 | 2,799 | — | $0 | 0 | SEC↗ |
| Levy Richard S | Director | A Award deriv | 2026-05-29 | 2026-06-02 | 2,026 | — | $0 | 2,026 | SEC↗ |
| Levy Richard S | Director | A Award deriv | 2026-05-29 | 2026-06-02 | 12,158 | — | $0 | 12,158 | SEC↗ |
| Malley Thomas | Director | A Award deriv | 2026-05-29 | 2026-06-02 | 2,026 | — | $0 | 2,026 | SEC↗ |
| Malley Thomas | Director | M Exercise deriv | 2026-05-29 | 2026-06-02 | 2,799 | — | $0 | 0 | SEC↗ |
| Malley Thomas | Director | A Award deriv | 2026-05-29 | 2026-06-02 | 12,158 | — | $0 | 12,158 | SEC↗ |
| McCain Tracey L | Director | A Award deriv | 2026-05-29 | 2026-06-02 | 12,158 | — | $0 | 12,158 | SEC↗ |
| McCain Tracey L | Director | M Exercise deriv | 2026-05-29 | 2026-06-02 | 2,799 | — | $0 | 0 | SEC↗ |
| McCain Tracey L | Director | A Award deriv | 2026-05-29 | 2026-06-02 | 2,026 | — | $0 | 2,026 | SEC↗ |
| Popovits Kimberly J | Director | A Award deriv | 2026-05-29 | 2026-06-02 | 12,158 | — | $0 | 12,158 | SEC↗ |
| Popovits Kimberly J | Director | M Exercise deriv | 2026-05-29 | 2026-06-02 | 2,799 | — | $0 | 0 | SEC↗ |
| Popovits Kimberly J | Director | A Award deriv | 2026-05-29 | 2026-06-02 | 2,026 | — | $0 | 2,026 | SEC↗ |
| Quart Barry D | Director | A Award deriv | 2026-05-29 | 2026-06-02 | 2,026 | — | $0 | 2,026 | SEC↗ |
| Quart Barry D | Director | M Exercise deriv | 2026-05-29 | 2026-06-02 | 2,799 | — | $0 | 0 | SEC↗ |
| Quart Barry D | Director | A Award deriv | 2026-05-29 | 2026-06-02 | 12,158 | — | $0 | 12,185 | SEC↗ |
| BAKER JULIAN | Director | A Award | 2026-05-29 | 2026-06-02 | 6,078 | — | $0 | 143,277 | SEC↗ |
| BAKER JULIAN | Director | A Award | 2026-05-29 | 2026-06-02 | 6,078 | — | $0 | 2,744,894 | SEC↗ |
| Cole G Bradley | Director | M Exercise | 2026-05-29 | 2026-06-02 | 2,799 | — | $0 | 15,345 | SEC↗ |
| Levy Richard S | Director | M Exercise | 2026-05-29 | 2026-06-02 | 2,799 | — | $0 | 21,956 | SEC↗ |
| Malley Thomas | Director | M Exercise | 2026-05-29 | 2026-06-02 | 2,799 | — | $0 | 15,345 | SEC↗ |
| McCain Tracey L | Director | M Exercise | 2026-05-29 | 2026-06-02 | 2,799 | — | $0 | 15,345 | SEC↗ |
| Popovits Kimberly J | Director | M Exercise | 2026-05-29 | 2026-06-02 | 2,799 | — | $0 | 15,345 | SEC↗ |
| Quart Barry D | Director | M Exercise | 2026-05-29 | 2026-06-02 | 2,799 | — | $0 | 15,345 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise deriv | 2026-05-01 | 2026-05-01 | 48,565 | — | $0 | 0 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-05-01 | 2026-05-05 | 58,424 | — | $0 | 29,670 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | S Sale | 2026-05-01 | 2026-05-01 | 48,565 | $54.02 | $2.62M | 0 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise | 2026-05-01 | 2026-05-01 | 48,565 | $30.93 | $1.50M | 48,565 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise | 2026-05-01 | 2026-05-05 | 58,424 | $10.36 | $605.3K | 124,047 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | S Sale | 2026-05-01 | 2026-05-05 | 21,097 | $54.04 | $1.14M | 65,623 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | S Sale | 2026-05-01 | 2026-05-05 | 37,327 | $53.52 | $2.00M | 86,720 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise deriv | 2026-04-30 | 2026-04-30 | 2,141 | — | $0 | 48,565 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise | 2026-04-30 | 2026-04-30 | 2,141 | $30.93 | $66.2K | 2,141 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | S Sale | 2026-04-30 | 2026-04-30 | 2,141 | $54.01 | $115.6K | 0 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise deriv | 2026-04-29 | 2026-04-30 | 22,544 | — | $0 | 50,706 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise | 2026-04-29 | 2026-04-30 | 22,544 | $30.93 | $697.3K | 22,544 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | S Sale | 2026-04-29 | 2026-04-30 | 22,544 | $54.01 | $1.22M | 0 | SEC↗ |
| Quart Barry D | Director | M Exercise deriv | 2026-04-28 | 2026-04-29 | 13,099 | — | $0 | 13,237 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise deriv | 2026-04-28 | 2026-04-30 | 431,904 | — | $0 | 0 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise deriv | 2026-04-28 | 2026-04-30 | 51,750 | — | $0 | 73,250 | SEC↗ |
| Quart Barry D | Director | S Sale | 2026-04-28 | 2026-04-29 | 13,099 | $50.10 | $656.3K | 12,546 | SEC↗ |
| Quart Barry D | Director | M Exercise | 2026-04-28 | 2026-04-29 | 13,099 | $14.33 | $187.7K | 25,645 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise | 2026-04-28 | 2026-04-30 | 431,904 | $10.36 | $4.47M | 431,904 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise | 2026-04-28 | 2026-04-30 | 51,750 | $30.93 | $1.60M | 483,654 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | S Sale | 2026-04-28 | 2026-04-30 | 74,635 | $50.43 | $3.76M | 409,019 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | S Sale | 2026-04-28 | 2026-04-30 | 113,673 | $51.47 | $5.85M | 295,346 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | S Sale | 2026-04-28 | 2026-04-30 | 243,596 | $52.02 | $12.67M | 51,750 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | S Sale | 2026-04-28 | 2026-04-30 | 51,750 | $54.02 | $2.80M | 0 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | S Sale | 2026-04-09 | 2026-04-13 | 1,703 | $46.69 | $79.5K | 12,029 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | S Sale | 2026-04-09 | 2026-04-13 | 6,625 | $46.69 | $309.3K | 27,418 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | M Exercise deriv | 2026-04-07 | 2026-04-08 | 3,932 | — | $0 | 0 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | M Exercise deriv | 2026-04-07 | 2026-04-08 | 2,477 | — | $0 | 0 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-04-07 | 2026-04-08 | 2,497 | — | $0 | 0 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise deriv | 2026-04-07 | 2026-04-08 | 9,991 | — | $0 | 0 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2026-04-07 | 2026-04-08 | 2,694 | — | $0 | 0 | SEC↗ |
| Tessari Eben | CHIEF STRATEGY OFFICER | M Exercise deriv | 2026-04-07 | 2026-04-08 | 2,726 | — | $0 | 0 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | F Tax w/h | 2026-04-07 | 2026-04-08 | 1,666 | $48.94 | $81.5K | 34,043 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | M Exercise | 2026-04-07 | 2026-04-08 | 3,932 | $1.00 | $3.9K | 35,709 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | M Exercise | 2026-04-07 | 2026-04-08 | 2,477 | — | $0 | 14,506 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | F Tax w/h | 2026-04-07 | 2026-04-08 | 774 | $48.94 | $37.9K | 13,732 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | F Tax w/h | 2026-04-07 | 2026-04-08 | 1,208 | $48.94 | $59.1K | 65,623 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise | 2026-04-07 | 2026-04-08 | 2,497 | — | $0 | 66,831 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise | 2026-04-07 | 2026-04-08 | 9,991 | — | $0 | 81,005 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | F Tax w/h | 2026-04-07 | 2026-04-08 | 4,831 | $48.94 | $236.4K | 76,174 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | F Tax w/h | 2026-04-07 | 2026-04-08 | 1,303 | $48.94 | $63.8K | 16,154 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise | 2026-04-07 | 2026-04-08 | 2,694 | — | $0 | 17,457 | SEC↗ |
| Tessari Eben | CHIEF STRATEGY OFFICER | M Exercise | 2026-04-07 | 2026-04-08 | 2,726 | — | $0 | 23,976 | SEC↗ |
| Tessari Eben | CHIEF STRATEGY OFFICER | F Tax w/h | 2026-04-07 | 2026-04-08 | 846 | $48.94 | $41.4K | 23,130 | SEC↗ |
| Quart Barry D | Director | M Exercise deriv | 2026-04-06 | 2026-04-08 | 6,901 | — | $0 | 26,336 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise deriv | 2026-04-06 | 2026-04-08 | 7,278 | — | $0 | 431,904 | SEC↗ |
| Quart Barry D | Director | S Sale | 2026-04-06 | 2026-04-08 | 6,901 | $50.00 | $345.1K | 12,546 | SEC↗ |
| Quart Barry D | Director | M Exercise | 2026-04-06 | 2026-04-08 | 6,901 | $14.33 | $98.9K | 19,447 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | S Sale | 2026-04-06 | 2026-04-08 | 2,367 | $48.58 | $115.0K | 12,029 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise | 2026-04-06 | 2026-04-08 | 7,278 | $10.36 | $75.4K | 7,278 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | S Sale | 2026-04-06 | 2026-04-08 | 7,278 | $50.01 | $364.0K | 0 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | A Award deriv | 2026-04-01 | 2026-04-03 | 7,300 | — | $0 | 7,300 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | A Award deriv | 2026-04-01 | 2026-04-03 | 3,650 | — | $0 | 3,650 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | M Exercise deriv | 2026-04-01 | 2026-04-03 | 2,558 | — | $0 | 2,557 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | M Exercise deriv | 2026-04-01 | 2026-04-03 | 2,362 | — | $0 | 4,725 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | A Award deriv | 2026-04-01 | 2026-04-03 | 14,600 | — | $0 | 14,600 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | M Exercise deriv | 2026-04-01 | 2026-04-03 | 2,644 | — | $0 | 7,931 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | M Exercise deriv | 2026-04-01 | 2026-04-03 | 1,740 | — | $0 | 3,481 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | M Exercise deriv | 2026-04-01 | 2026-04-03 | 2,457 | — | $0 | 7,371 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | M Exercise deriv | 2026-04-01 | 2026-04-03 | 1,611 | — | $0 | 1,161 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | A Award deriv | 2026-04-01 | 2026-04-03 | 18,500 | — | $0 | 18,500 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | A Award deriv | 2026-04-01 | 2026-04-03 | 9,250 | — | $0 | 9,250 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | A Award deriv | 2026-04-01 | 2026-04-03 | 36,950 | — | $0 | 36,950 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-04-01 | 2026-04-03 | 2,457 | — | $0 | 7,371 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-04-01 | 2026-04-03 | 1,750 | — | $0 | 3,500 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-04-01 | 2026-04-03 | 1,624 | — | $0 | 1,624 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | A Award deriv | 2026-04-01 | 2026-04-03 | 13,400 | — | $0 | 13,400 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | A Award deriv | 2026-04-01 | 2026-04-03 | 26,750 | — | $0 | 26,750 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | A Award deriv | 2026-04-01 | 2026-04-03 | 6,700 | — | $0 | 6,700 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise deriv | 2026-04-01 | 2026-04-03 | 6,481 | — | $0 | 6,481 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | A Award deriv | 2026-04-01 | 2026-04-03 | 120,150 | — | $0 | 120,150 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | A Award deriv | 2026-04-01 | 2026-04-03 | 30,050 | — | $0 | 30,050 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | A Award deriv | 2026-04-01 | 2026-04-03 | 60,100 | — | $0 | 60,100 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise deriv | 2026-04-01 | 2026-04-03 | 6,237 | — | $0 | 12,475 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise deriv | 2026-04-01 | 2026-04-03 | 8,609 | — | $0 | 25,826 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2026-04-01 | 2026-04-03 | 1,591 | — | $0 | 3,182 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2026-04-01 | 2026-04-03 | 1,750 | — | $0 | 1,750 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | A Award deriv | 2026-04-01 | 2026-04-03 | 15,600 | — | $0 | 15,600 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2026-04-01 | 2026-04-03 | 1,846 | — | $0 | 5,536 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | A Award deriv | 2026-04-01 | 2026-04-03 | 31,150 | — | $0 | 31,150 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | A Award deriv | 2026-04-01 | 2026-04-03 | 7,800 | — | $0 | 7,800 | SEC↗ |
| Tessari Eben | CHIEF STRATEGY OFFICER | M Exercise deriv | 2026-04-01 | 2026-04-03 | 1,773 | — | $0 | 1,772 | SEC↗ |
| Tessari Eben | CHIEF STRATEGY OFFICER | A Award deriv | 2026-04-01 | 2026-04-03 | 33,200 | — | $0 | 33,200 | SEC↗ |
| Tessari Eben | CHIEF STRATEGY OFFICER | M Exercise deriv | 2026-04-01 | 2026-04-03 | 2,457 | — | $0 | 7,371 | SEC↗ |
| Tessari Eben | CHIEF STRATEGY OFFICER | M Exercise deriv | 2026-04-01 | 2026-04-03 | 1,745 | — | $0 | 3,490 | SEC↗ |
| Tessari Eben | CHIEF STRATEGY OFFICER | A Award deriv | 2026-04-01 | 2026-04-03 | 16,600 | — | $0 | 16,600 | SEC↗ |
| Tessari Eben | CHIEF STRATEGY OFFICER | A Award deriv | 2026-04-01 | 2026-04-03 | 8,300 | — | $0 | 8,300 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | F Tax w/h | 2026-04-01 | 2026-04-03 | 3,205 | $48.13 | $154.3K | 31,777 | SEC↗ |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | M Exercise | 2026-04-01 | 2026-04-03 | 7,564 | — | $0 | 34,982 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | F Tax w/h | 2026-04-01 | 2026-04-03 | 1,706 | $48.13 | $82.1K | 14,396 | SEC↗ |
| Moat Ross | CHIEF OPERATING OFFICER | M Exercise | 2026-04-01 | 2026-04-03 | 5,808 | — | $0 | 16,102 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise | 2026-04-01 | 2026-04-03 | 5,831 | — | $0 | 67,155 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | F Tax w/h | 2026-04-01 | 2026-04-03 | 2,821 | $48.13 | $135.8K | 64,334 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | F Tax w/h | 2026-04-01 | 2026-04-03 | 10,313 | $48.13 | $496.4K | 71,014 | SEC↗ |
| Patel Sanj K | CHAIRMAN & CEO | M Exercise | 2026-04-01 | 2026-04-03 | 21,327 | — | $0 | 81,327 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise | 2026-04-01 | 2026-04-03 | 5,187 | — | $0 | 17,273 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | F Tax w/h | 2026-04-01 | 2026-04-03 | 2,510 | $48.13 | $120.8K | 14,763 | SEC↗ |
| Tessari Eben | CHIEF STRATEGY OFFICER | F Tax w/h | 2026-04-01 | 2026-04-03 | 1,756 | $48.13 | $84.5K | 21,250 | SEC↗ |
| Tessari Eben | CHIEF STRATEGY OFFICER | M Exercise | 2026-04-01 | 2026-04-03 | 5,975 | — | $0 | 23,006 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2026-03-09 | 2026-03-11 | 10,513 | — | $0 | 18,396 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2026-03-09 | 2026-03-11 | 13,813 | — | $0 | 19,337 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2026-03-09 | 2026-03-11 | 10,360 | — | $0 | 22,790 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2026-03-09 | 2026-03-11 | 2,036 | — | $0 | 0 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | S Sale | 2026-03-09 | 2026-03-11 | 17,981 | $45.58 | $819.6K | 30,827 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | S Sale | 2026-03-09 | 2026-03-11 | 18,741 | $46.24 | $866.6K | 12,086 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise | 2026-03-09 | 2026-03-11 | 10,360 | $26.74 | $277.0K | 48,808 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise | 2026-03-09 | 2026-03-11 | 13,813 | $18.06 | $249.5K | 38,448 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise | 2026-03-09 | 2026-03-11 | 10,513 | $17.76 | $186.7K | 24,635 | SEC↗ |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | M Exercise | 2026-03-09 | 2026-03-11 | 2,036 | $22.89 | $46.6K | 14,122 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise deriv | 2026-03-02 | 2026-03-04 | 40,000 | — | $0 | 58,424 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | S Sale | 2026-03-02 | 2026-03-04 | 12,063 | $44.20 | $533.2K | 89,261 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | S Sale | 2026-03-02 | 2026-03-04 | 22,223 | $44.88 | $997.4K | 67,038 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | S Sale | 2026-03-02 | 2026-03-04 | 5,714 | $45.92 | $262.4K | 61,324 | SEC↗ |
| Paolini John F. | CHIEF MEDICAL OFFICER | M Exercise | 2026-03-02 | 2026-03-04 | 40,000 | $10.36 | $414.4K | 101,324 | SEC↗ |
| Quart Barry D | Director | M Exercise deriv | 2026-02-12 | 2026-02-12 | 2,690 | — | $0 | 0 | SEC↗ |
| Quart Barry D | Director | M Exercise | 2026-02-12 | 2026-02-12 | 2,690 | $15.47 | $41.6K | 15,236 | SEC↗ |